2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
Author(s) -
Sylvie Jaillard,
Christèle Dubourg,
Marion GérardBlanluet,
Andrée DelahayeDuriez,
Laurent Pasquier,
Céline Dupont,
Cathérine Henry,
A-C Tabet,
Josette Lucas,
Azzedine Aboura,
Véronique David,
Brigitte Benzacken,
Sylvie Odent,
Eva Pipiras
Publication year - 2008
Publication title -
journal of medical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.439
H-Index - 170
eISSN - 1468-6244
pISSN - 0022-2593
DOI - 10.1136/jmg.2008.058156
Subject(s) - genetics , haploinsufficiency , microdeletion syndrome , comparative genomic hybridization , biology , microcephaly , angelman syndrome , phenotype , ataxia , chromosome , gene , neuroscience
Genome-wide screening of patients with mental retardation using array comparative genomic hybridisation (CGH) has identified several novel imbalances. With this genotype-first approach, the 2q22.3q23.3 deletion was recently described as a novel microdeletion syndrome. The authors report two unrelated patients with a de novo interstitial deletion mapping in this genomic region and presenting similar "pseudo-Angelman" phenotypes, including severe psychomotor retardation, speech impairment, epilepsy, microcephaly, ataxia, and behavioural disabilities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom